Description
Discussion: Financing of Health Care
With coinciding concerns about health care costs and the imperative to improve quality of care, health care providers and others face difficult decisions in the effort to achieve an appropriate balance. Such decisions often are addressed in the policy arena. How do policymakers evaluate which health care services should be financed through government programs? How do ethics-related questions and other considerations play into this evaluation process? Is it possible to contain costs and provide accessible, high-quality care to all, or is the tension between cost and care inherent in the U.S. health care delivery system? These questions are central to health care financing decisions in the United States.
For this Discussion, you will focus on the policy decision-making process that determines what types of care are covered by public and private insurers and the ethical aspects of such financial decisions.
To prepare:
- Read the the case study “Economic Impact of States Declining Medicaid Expansion” page 305 of the Milstead text.
- Review the information in the Washington Post article “Review of Prostate Cancer Drugs Provenge Renews Medical Cost-Benefit Debate” in the Learning Resources.
- Consider how policy decisions currently are made about what will and will not be paid for and what changes, if any, could improve the process.
- Reflect on how the Washington Post example illustrates the tension between cost and care.
By Day 3
Post your analysis and assessment of the ethical and economic challenges related to policy decisions such as those presented in the Washington Post article. How does this type of situation contribute to the tension between cost and care? Substantiate your response with at least two outside resources.
By Day 6
Respond to at least two of your colleagues on two different days in one or more of the following ways:
- Ask a probing question, substantiated with additional background information, evidence, or research using an in-text citation in APA format.
- Share an insight from having read your colleagues’ postings, synthesizing the information to provide new perspectives.
- Offer and support an alternative perspective using readings from the classroom or from your own research in the Walden Library.
- Validate an idea with your own experience and additional research.
- Make a suggestion based on additional evidence drawn from readings or after synthesizing multiple postings.
- Expand on your colleagues’ postings by providing additional insights or contrasting perspectives based on readings and evidence.
Unformatted Attachment Preview
Purchase answer to see full attachment
Explanation & Answer
Attached.
Running Head: FINANCING OF HEALTHCARE
Financing of Healthcare
Student’s Name
Instructor
Institutional Affiliation
Date
1
FINANCING OF HEALTHCARE
2
Choices concerning policy are related to various sorts of ethical and moral difficulties.
An ultimate conclusion is firmly affected by both financial and ethical ramifications. Lately, the
Federal Government has set up different measures to streamline the country's health services
system. In 2010, the Federal Government tried to incorporate Provenge drugs into Medicare's
treatment plans (Kingdon & Thurber, 2010). This move cocked eyebrows from most
shareholders including a few individuals from the general public. For the most part, Medicare
ought not to consider costs while settling on decisions. Then again, a significant number of
people felt that the Provenge medication was excessively costly for inclusion in the Medicare's
treatment scheme. This issue exhibits an excellent case of how policy and cost issues influence
the decision-making process regarding policy.
Though it is unethical for Medicare's choice to be impacted by pricing, it is additionally
not economical for the administration to foot the enormous bills related to cancer medication
(Henderson, 2012). The United States has one of the efficient and costly health services systems.
It is consequently vital for the government to devise cost-cutting alternatives. By including the
expensive Provenge medication into Medicare's system, Americans would be compelled to
cough up a higher amount of tax. Treatment of prostate cancer utilizing the Provenge drug costs
greater than $90,000 for each patient (Kingdon & Thurber, 2010). This value is expensive from a
financial perspective considering that the medication just prolongs the patient's life by a couple
of months. In any case, this problem raises delicate issues from a moral point of view. As
specified before,...